| Dr Visalakshi Rao Vallury, MD | |
|
5971 Virginia Pkwy Ste 100, Mckinney, TX 75071-5618 | |
| (972) 791-8301 | |
| (469) 678-7312 |
| Full Name | Dr Visalakshi Rao Vallury |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 5971 Virginia Pkwy Ste 100, Mckinney, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174528061 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | N4818 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
| Metroplex Care Group | 8022239565 | 6 |
News Archive
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
West Nile virus may be much more deadly than previously believed, with deaths attributable to the mosquito-borne disease occurring not just in the immediate aftermath of the infection but also years later, long after patients seem to have recovered from the initial illness, according to a new study presented today at the 2016 Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH)
In her keynote address to the 32nd American Pain Society Annual Scientific Conference, Story Landis, PhD, director of the National Institute for Neurological Disorders and Stroke, told the APS audience that NIH is committed to research to improve understanding of the biological basis of pain and the development of effective treatments.
Researchers from Boston University's Slone Epidemiology Center have found that exposure to pseudoephedrine, a decongestant found in many cough-and-cold and allergy medications, has been common among U.S. children, especially those under the age of two years who are at the highest risk for toxicity and for whom safe dosing recommendations are lacking.
› Verified 7 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
West Nile virus may be much more deadly than previously believed, with deaths attributable to the mosquito-borne disease occurring not just in the immediate aftermath of the infection but also years later, long after patients seem to have recovered from the initial illness, according to a new study presented today at the 2016 Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH)
In her keynote address to the 32nd American Pain Society Annual Scientific Conference, Story Landis, PhD, director of the National Institute for Neurological Disorders and Stroke, told the APS audience that NIH is committed to research to improve understanding of the biological basis of pain and the development of effective treatments.
Researchers from Boston University's Slone Epidemiology Center have found that exposure to pseudoephedrine, a decongestant found in many cough-and-cold and allergy medications, has been common among U.S. children, especially those under the age of two years who are at the highest risk for toxicity and for whom safe dosing recommendations are lacking.
› Verified 7 days ago
| Entity Name | Metroplex Care Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043627870 PECOS PAC ID: 8022239565 Enrollment ID: O20141024002081 |
News Archive
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
West Nile virus may be much more deadly than previously believed, with deaths attributable to the mosquito-borne disease occurring not just in the immediate aftermath of the infection but also years later, long after patients seem to have recovered from the initial illness, according to a new study presented today at the 2016 Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH)
In her keynote address to the 32nd American Pain Society Annual Scientific Conference, Story Landis, PhD, director of the National Institute for Neurological Disorders and Stroke, told the APS audience that NIH is committed to research to improve understanding of the biological basis of pain and the development of effective treatments.
Researchers from Boston University's Slone Epidemiology Center have found that exposure to pseudoephedrine, a decongestant found in many cough-and-cold and allergy medications, has been common among U.S. children, especially those under the age of two years who are at the highest risk for toxicity and for whom safe dosing recommendations are lacking.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Visalakshi Rao Vallury, MD 700 N Pearl St Ste N510, Dallas, TX 75201-2863 Ph: (214) 580-7277 | Dr Visalakshi Rao Vallury, MD 5971 Virginia Pkwy Ste 100, Mckinney, TX 75071-5618 Ph: (972) 791-8301 |
News Archive
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
West Nile virus may be much more deadly than previously believed, with deaths attributable to the mosquito-borne disease occurring not just in the immediate aftermath of the infection but also years later, long after patients seem to have recovered from the initial illness, according to a new study presented today at the 2016 Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH)
In her keynote address to the 32nd American Pain Society Annual Scientific Conference, Story Landis, PhD, director of the National Institute for Neurological Disorders and Stroke, told the APS audience that NIH is committed to research to improve understanding of the biological basis of pain and the development of effective treatments.
Researchers from Boston University's Slone Epidemiology Center have found that exposure to pseudoephedrine, a decongestant found in many cough-and-cold and allergy medications, has been common among U.S. children, especially those under the age of two years who are at the highest risk for toxicity and for whom safe dosing recommendations are lacking.
› Verified 7 days ago
George W Childress, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6171 Virginia Pkwy Ste 200, Mckinney, TX 75071 Phone: 972-548-5377 Fax: 972-548-5447 | |
Melony Ann Chilcoat, APRN, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2740 Virginia Pkwy Ste 100, Mckinney, TX 75071 Phone: 214-414-2880 Fax: 214-279-9639 | |
Dr. Kedrica Massa Taylor, DNP, APRN, FNP-BC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1703 Rockhill Rd Apt 1131, Mckinney, TX 75069 Phone: 918-408-0560 | |
Dr. John L Washburn Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5220 W University Dr Ste 100, Mckinney, TX 75071 Phone: 469-800-5100 Fax: 469-800-5110 | |
Tina M Gingrich, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4510 Medical Center Dr, Mckinney, TX 75069 Phone: 214-295-8675 Fax: 866-207-2534 | |
Ambreen Ashfaque, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4201 Medical Center Dr, Suite 380, Mckinney, TX 75069 Phone: 972-529-6939 Fax: 972-529-6935 | |
Mr. Billy R Boring Jr., MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1441 Redbud Blvd, Ste 111, Mckinney, TX 75069 Phone: 972-542-2683 Fax: 972-548-7657 |